Project Grant HT94252510829
Award Date
9/1/25
Completion Date
8/31/28
Dollars Obligated
$507K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
The federal Project Grant award of $777,537 was granted by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The award supports research to investigate associations between blood-based neurodegenerative biomarker trajectories and the risk of epilepsy, post-traumatic epilepsy, and dementia. This 3-year research project,...
The federal Project Grant award for "NEUROPHYSIOLOGY OF POST-TRAUMATIC EPILEPSY: UNRAVELING EPILEPTOGENESIS SIGNALS BIOMARKERS" was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $860,998 award to The Regents of the University of California, San Francisco (UCSF) supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. The project will investigate...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development Program (CFDA 12.420) provides $2,495,419.00 to The Trustees of the University of Pennsylvania (Penn) to develop a blood-based biomarker for detecting blood-brain barrier dysfunction in traumatic brain injury. The project aims to transform healthcare for service members and the public by developing innovative medical solutions for the battlefield through July 1, 2023 to June 30, 2027....
This federal Project Grant award of $707,436.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research to investigate "Biomarker Signatures of Post-Traumatic Epileptogenesis (PTEGenesis) and Its Treatments". The primary awardee is the Albert Einstein College of Medicine, a private non-profit educational institution, which is conducting this advanced biomedical research. The project includes a sub-award to...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $683,442 Project Grant on September 1, 2023 to The Trustees of the University of Pennsylvania to conduct a 3-year study on "Trajectories of Neuroimaging and Blood-Based Biomarkers After Remote Traumatic Brain Injury and Associations with Dementia Risk." The University of Pennsylvania will collaborate with Mayo Clinic on a sub-award to investigate longitudinal changes in brain...
The federal Project Grant award of $946,873.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research to investigate the genetic risk of prostate cancer in self-identified Black veterans. The award was granted to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, a prominent private research university and academic medical center in Philadelphia. The research...
This $1,199,997.00 Project Grant award from the Defense Health Agency, under the Department of Defense's Military Medical Research and Development program (CFDA 12.420), is funding research to prevent trauma-related infections during prolonged care. The grant was awarded on Sep 30, 2023 to The Trustees Of The University Of Pennsylvania - doing business as Clinical Practices Of The University Of Pennsylvania, a private university and non-profit research institution. The research aims to develop...
The Project Grant award, titled "PROGRAM TO CHARACTERIZE EVOLVING ENDOPHENOTYPES OF DEGENERATION AFTER TRAUMATIC BRAIN INJURY (PROCEED-TBI)", was provided by the Defense Health Agency for $7,956,997.00 with a period of performance from September 30, 2023 to September 29, 2027. The grant supports biomedical research related to the Military Medical Research and Development program (CFDA 12.420), with a focus on characterizing clinically relevant animal models of traumatic brain injury...
The federal Project Grant award of $1,072,500.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant is funding research at Tufts University School of Medicine to investigate reducing post-traumatic epilepsy by blocking MIAT signaling in parvalbumin-positive inhibitory GABAergic interneurons. The research aims to transform healthcare for military service members, veterans, and the broader public by addressing critical...
This $819,195 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by Drexel University on the PEDF PLXDC1 ADNP signaling pathways related to neuromorphogenesis and neural circuit development. The award, which runs from September 15, 2023 to September 14, 2026, will fund basic, translational, and clinical research aimed at advancing scientific understanding and developing new treatments in areas such as...